Rakhee Vaidya to T-Lymphocytes
This is a "connection" page, showing publications Rakhee Vaidya has written about T-Lymphocytes.
Connection Strength
0.031
-
Lamar ZS, Fino N, Palmer J, Gruber L, Morris BB, Raetskaya-Solntseva O, Kennedy L, Vaidya R, Hurd D, Zamkoff K. Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk. 2016 Feb; 16(2):76-81.
Score: 0.031